Global Vendor Neutral Archive Market, By Deployment Model, By Vendor Type (Independent Software Vendors, PACS Vendors, Infrastructure Vendors), By Imaging Type, By End User, By Geography .

Description

The global vendor neutral archive (VNA) market was valued US$ 3.96 Bn in 2023 and is expected to reach US$ 5.93 Bn by 2031 growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 3.96 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	5.20%	2030/2031 Value Projection:	US$ 5.93 Bn

Figure 1. Global Vendor Neutral Archive (VNA) Market Share (%), By Region, 2023

Global Vendor Neutral Archive Market - IMG1

Vendor neutral archive (VNA) is an image management solution that allows medical images and associated reports to be stored, queried, and retrieved by any healthcare application from multiple sources and modalities. Traditionally, healthcare organizations have had to manage multiple PACS systems to store and access radiology images which led to increased costs and technological complexities. A VNA provides a central repository that consolidates imaging data from all departments, sources, and specialties in a single archive. This facilitates interoperability, universal access, and optimized care collaboration.

Market Dynamics:

The growth of the vendor neutral archive (VNA) market is driven by factors such as rising imaging volumes due to increasing prevalence of chronic diseases, growing preferences for centralized medical imaging storage systems, and need to improve data sharing and enhance patient care coordination across various care delivery settings. However, high costs associated with the deployment and maintenance of VNAs as well as lack of expertise especially in small healthcare facilities limit their widespread adoption. Meanwhile, growing telehealth practices, technological advancements to enable artificial intelligence integration, and predictive analytics present lucrative opportunities for vendors.

Key features of the study:

This report provides an in-depth analysis of the global vendor neutral archive (VNA) market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global vendor neutral archive (VNA) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Johnson & Johnson Private Limited, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Baxter, Bayer AG, Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin , Allergan, AbbVie Inc., Abbott, Bausch Health Companies Inc. , Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, and AstraZeneca
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global vendor neutral archive (VNA) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vendor neutral archive (VNA) market

Detailed Segmentation:

Global Vendor Neutral Archive (VNA) Market, By Deployment Model
- On-Premise VNA
- Cloud-Based VNA
Global Vendor Neutral Archive (VNA) Market, By Vendor Type
- Independent Software Vendors (ISVs)
- PACS Vendors
- Infrastructure Vendors
Global Vendor Neutral Archive (VNA) Market, By Imaging Type
- Radiology VNAs
- Cardiology VNAs
- Pathology VNAs
Global Vendor Neutral Archive (VNA) Market, By End-User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Care Centers
- Research and Academic Institutes
Global Vendor Neutral Archive (VNA) Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Global Vendor Neutral Archive (VNA) Market, Key Players
- Johnson & Johnson Private Limited
- Merck & Co., Inc.
- F.Hoffmann-La Roche Ltd.
- Baxter
- Bayer AG
- Eli Lilly and Company
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lupin
- Allergan
- AbbVie Inc.
- Abbott
- Bausch Health Companies Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- AstraZeneca

Product Code: CMI6654

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Vendor Neutral Archive (VNA) Market, By Deployment Model
- Global Vendor Neutral Archive (VNA) Market, By Vendor Type
- Global Vendor Neutral Archive (VNA) Market, By Imaging Type
- Global Vendor Neutral Archive (VNA) Market, By End User
- Global Vendor Neutral Archive (VNA) Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing adoption of cloud-based VNA solutions
- Growing adoption of imaging equipment across healthcare facilities
Impact Analysis
Key Highlights
Regulatory Scenario
Service Offering Portfolio
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Pipeline Analysis

4. Global Vendor Neutral Archive (VNA) Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Vendor Neutral Archive (VNA) Market, By Deployment Model, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
On-premise VNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Cloud-based VNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Vendor Neutral Archive (VNA) Market, By Vendor Type, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Independent Software Vendors (ISVs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
PACS Vendors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Infrastructure Vendors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Vendor Neutral Archive (VNA) Market, By Imaging Type, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Radiology VNAs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Cardiology VNAs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Pathology VNAs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Vendor Neutral Archive (VNA) Market, By End User, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Ambulatory Care Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Vendor Neutral Archive (VNA) Market, By Region, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019 - 2031
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
- U.S.
- Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2019-2031,(US$ Bn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Johnson & Johnson Private Limited
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
F. Hoffmann-La Roche Ltd.
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Baxter
- Company Highlights
- Deployment Model Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bayer AG
Eli Lilly and Company
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma
Lupin
Allergan
AbbVie Inc.
Abbott
Bausch Health Companies Inc.
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi
AstraZeneca
Analyst Views

11. Section

Research Methodology
About us